Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer

類似資料

• Neoadjuvant Dose-dense Gemcitabine and Cisplatin in Muscle-invasive Bladder Cancer: Results of a Phase 2 Trial
  著者:: Anari, Fern, 等
  出版事項: (2018)
• Defects in DNA Repair Genes Confer Improved Long-term Survival after Cisplatin-based Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer
  著者:: Miron, Benjamin, 等
  出版事項: (2020)
• Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Is Safe, Effective, and Efficient Neoadjuvant Treatment for Muscle-Invasive Bladder Cancer: Results of a Multicenter Phase II Study With Molecular Correlates of Response and Toxicity
  著者:: Plimack, Elizabeth R., 等
  出版事項: (2014)
• Coexisting hybrid malignancy in a solitary sporadic solid benign renal mass: implications for managing patients following renal biopsy
  著者:: Ginzburg, Serge, 等
  出版事項: (2013)
• Numb Independently Antagonizes Sanpodo Membrane Targeting and Notch Signaling in Drosophila Sensory Organ Precursor Cells
  著者:: Tong, Xin, 等
  出版事項: (2010)